Atorvastatin Effect on Contrast Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention
Status:
Completed
Trial end date:
2020-05-05
Target enrollment:
Participant gender:
Summary
Investigate of the potential benefit of acute pretreatment with high dose atorvastatin (80
mg) in reduction of the incidence of CIN in diabetic patients indicated for elective coronary
intervention.